Sign up to save your podcasts
Or
Share Obesity Epidemic and New GLP-1Drugs (Ozempic/Mounjaro).
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Obesity Epidemic and New GLP-1Drugs (Ozempic/Mounjaro).
Chief Clinical Officer at Discovery Health, Dr Noluthando Nematswerani on the effects of non-diabetic consumers abusing diabetes medicine like GLP-1Drugs (Ozempic/Mounjaro) for weight loss purposes. This after reports of supply shortages and ration how many injection pens filled with human insulin, for the treatment of diabetes.
See omnystudio.com/listener for privacy information.
View all episodes
By 702
5
11 ratings
Chief Clinical Officer at Discovery Health, Dr Noluthando Nematswerani on the effects of non-diabetic consumers abusing diabetes medicine like GLP-1Drugs (Ozempic/Mounjaro) for weight loss purposes. This after reports of supply shortages and ration how many injection pens filled with human insulin, for the treatment of diabetes.
See omnystudio.com/listener for privacy information.
More shows like The Best of 702 Weekend Breakfast
View all
Afternoons with Relebogile Mabotja
3 Listeners
The Daily
112,751 Listeners
The Clement Manyathela Show
13 Listeners
The Best of Breakfast with Bongani Bingwa
2 Listeners
Anele and the Club on 947
2 Listeners
BizNews Radio
16 Listeners
The Aubrey Masango Show
3 Listeners
What Now? with Trevor Noah
4,240 Listeners
The Corder Report Powered by eNCA.com
6 Listeners